论文部分内容阅读
目的:探究在急性心衰合并快速心率失常治疗中应用胺碘酮的临床效果。方法:择取我院于2016年4月到2017年4月收治的110例急性心衰合并快速心律失常的患者,将其以随机的方式分为实验组与参照组,各55例。参照组予以常规性治疗,实验组则在此基础上加用胺碘酮治疗,对比两组的治疗总有效率以及不良反应情况的发生率。结果:实验组的治疗总体有效率为92.73%,显著高于参照组的81.82%;实验组的不良反应总发生率为12.73%,显著低于参照组的30.91%。各差异均满足P<0.05,差异在统计学中存在意义。结论:对急性心衰合并快速心率失常患者予以胺碘酮治疗能够明显改善治疗效果,其实用性与安全性均相对较高,可将其推广使用。
Objective: To investigate the clinical effect of amiodarone in the treatment of acute heart failure complicated with rapid arrhythmia. Methods: A total of 110 patients with acute heart failure complicated with tachyarrhythmia admitted from April 2016 to April 2017 in our hospital were randomly divided into experimental group and reference group (55 cases each). The reference group was given routine treatment, and the experimental group was treated with amiodarone on the basis of the above. The total effective rate and the incidence of adverse reactions in the two groups were compared. Results: The total effective rate of the experimental group was 92.73%, which was significantly higher than that of the reference group (81.82%). The total incidence of adverse reactions in the experimental group was 12.73%, significantly lower than that of the reference group (30.91%). The differences all meet P <0.05, and the differences have statistical significance. Conclusion: Amiodarone in patients with acute heart failure complicated with rapid arrhythmia can obviously improve the therapeutic effect, and its practicality and safety are relatively high, so it can be widely used.